Some earlier studies also reported an oncogenic role for SOX9, based on the observation that SOX9 inhibition via RNA-inhibitory approaches reduced cell growth and the tumorigenic potential of CRC cells in immunocompromised mice (21, 22). Here, SOX9 is linked to colorectal carcinoma.